Tomp Freeman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Strong evidence of both benefits and harms for a range of medical indications Cannabis is used by an estimated 219 million adults globally (4.3% of the population) with a particularly high prevalence in North America (17.4% of the population).1 The 1961 UN Single Convention on Narcotic Drugs included cannabis with opioids and cocaine as a controlled substance whose use was prohibited, but policies have changed considerably in recent decades. Medical use of cannabis is now permitted in large parts of North and South America, Europe, and Oceania; although, patient access varies considerably acro...

National and international policies are key to reducing use and harm Synthetic cannabinoids, colloquially known as “spice,” are a class of structurally diverse novel psychoactive substances that were originally designed to mimic the effects of Δ9-tetrahydrocannabinol, the main psychoactive compound in cannabis. In 2022, the European Monitoring Centre for Drugs and Drug Addiction was monitoring 224 synthetic cannabinoids,1 with new variations emerging every year. These drugs can produce strong effects at low doses, with potential for serious harms such as addiction and withdrawal, psychosi...

Policymakers should consider potency when regulating cannabis, researchers urge